# Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction

> **NCT06710184** · PHASE4 · RECRUITING · sponsor: **University of Aarhus** · enrollment: 5076 (estimated)

## Conditions studied

- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Acute Myocardial Infarction (AMI)

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Fondaparinux Sodium

## Key facts

- **NCT ID:** NCT06710184
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 5076 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710184, "Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06710184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*